Association of treatment-achieved HbA
Angiogenesis Inhibitors
/ therapeutic use
Coronary Artery Disease
/ epidemiology
Diabetes Mellitus, Type 2
/ metabolism
Diabetic Retinopathy
/ epidemiology
Diet, Diabetic
Female
Glycated Hemoglobin
/ metabolism
Humans
Hypoglycemic Agents
/ therapeutic use
Incidence
Insulin
/ therapeutic use
Intravitreal Injections
Light Coagulation
Macular Edema
/ epidemiology
Male
Middle Aged
Proportional Hazards Models
Severity of Illness Index
Sulfonylurea Compounds
/ therapeutic use
Treatment Outcome
Antidiabetic drug
Cardiovascular disease
Cohort study
Diabetic retinopathy
Macrovascular disease
Journal
Diabetes & metabolism
ISSN: 1878-1780
Titre abrégé: Diabetes Metab
Pays: France
ID NLM: 9607599
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
16
04
2018
revised:
21
08
2018
accepted:
21
08
2018
pubmed:
15
9
2018
medline:
3
11
2021
entrez:
15
9
2018
Statut:
ppublish
Résumé
To examine the association between treatment-achieved HbA Associations of treatment-achieved HbA A significant linear trend was associated with HbA These findings suggest that the relationship between treatment-achieved HbA
Identifiants
pubmed: 30213710
pii: S1262-3636(18)30167-8
doi: 10.1016/j.diabet.2018.08.009
pii:
doi:
Substances chimiques
Angiogenesis Inhibitors
0
Glycated Hemoglobin A
0
Hypoglycemic Agents
0
Insulin
0
Sulfonylurea Compounds
0
hemoglobin A1c protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
331-334Informations de copyright
Copyright © 2018 Elsevier Masson SAS. All rights reserved.